Wistar scientists identify novel therapeutic approach to re-activate immune response against tumors – BIOENGINEER.ORG

PHILADELPHIA – (June 21, 2022) – Due to the development of resistance to chemotherapy and recurrent tumors, patients with ovarian cancer often have low survival rates. Therefore, new therapeutic options such as targeted therapy that boosts antitumor immunity are needed to improve ovarian cancer treatment efficacy and patient survival. PHILADELPHIA – (June 21, 2022) – … Read more

New Study Identifies Potential Therapeutic Target for

WASHINGTON, June 06, 2022 (GLOBE NEWSWIRE) – A recently published article in Experimental Biology and Medicine (Volume 247, Issue 10, May, 2022) identifies a potentially important personalized therapy for gastric cancer treatment. The study, led by Dr. Guohua Wang at the Institute of Special Environmental Medicine at Nantong University (China), reports that blocking Musashi-1 expression … Read more

Repurposed Antibiotic May Be an Effective COVID-19 Therapeutic

Researchers, looking to identify potential antiviral therapies that are effective against COVID-19, found that the antibiotic clofoctol may be an effective treatment for SARS-CoV-2 infections in mice. Study in mice suggests Clofoctol inhibits[{” attribute=””>SARS-CoV-2 replication and reduces lung pathology. Repurposed drugs often have a speedier path to clinical use because they have already been shown … Read more

Rapid Therapeutic Science Laboratories to Attend the

DALLAS, April 28, 2022 (GLOBE NEWSWIRE) – Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic ” or the” Company “), a growth-oriented aerosol manufacturing company focused on natural relief innovations through trusted aerosol delivery , announces today that its senior management and senior scientists have been invited to attend the Respiratory Drug Delivery (RDD) 2022 … Read more

Researchers identify therapeutic target for aggressive blood cancer – BIOENGINEER.ORG

A new study published today in the journal Genes & Development reveals a gene that normally suppresses the formation of tumors but is reprogrammed at the onset of acute promyelocytic leukemia (APL), an aggressive type of blood cancer that is responsible for 5-15% of all types of leukemia. A new study published today in the … Read more

A new toolkit to engineer safe and efficient therapeutic cells – BIOENGINEER.ORG

SAN FRANCISCO, CA—April 15, 2022 — Therapies based on engineered immune cells have recently emerged as a promising approach in the treatment of cancer. Compared to traditional drugs, engineered immune cells are more precise and sophisticated in their ability to detect and eliminate cancer cells. SAN FRANCISCO, CA—April 15, 2022 — Therapies based on engineered … Read more

Oregon State research helps provide scientific framework for psilocybin use in therapeutic settings – BIOENGINEER.ORG

CORVALLIS, Ore. – A new paper by an Oregon State University-led research team provides a scientific framework to help shape the rollout of a program in Oregon that will legally allow the use of psilocybin for therapeutic reasons. CORVALLIS, Ore. – A new paper by an Oregon State University-led research team provides a scientific framework … Read more

Newly identified neutrophil subset is a promising therapeutic target – BIOENGINEER.ORG

Using a protein nanoparticle they designed, scientists at the University of Illinois Chicago have identified two distinct subtypes of neutrophils and found that one of the subtypes can be used as a drug target for inflammatory diseases. Credit: Bachmaier, et al. ACS Nano Using a protein nanoparticle they designed, scientists at the University of Illinois … Read more

Insilico Medicine identifies potential dual-purpose therapeutic targets implicated in aging and age-associated diseases using Artificial Intelligence and hallmarks of aging framework

March 29, 2022, New York – Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI) -driven drug discovery company, today announced that it has created a unique approach for identifying potential dual-purpose therapeutic targets for aging and age-associated diseases with PandaOmics, its proprietary AI-enabled biological target discovery platform. The research supporting this approach was published … Read more

uOttawa scientists collaborate to identify new drug for unique therapeutic approach – BIOENGINEER.ORG

A Faculty of Medicine team from the University of Ottawa and their international collaborators have shown proof of concept for an entirely new therapeutic approach in treating tuberculosis (TB), an enduring and recently accelerating scourge that is the leading cause of death worldwide by a bacterial infection. . The disease is caused by a bacterium, … Read more